Profiel
Dr. S.
K.
Tanaka is Vice President-Research & Development at Paratek Pharmaceuticals, Inc.
Dr. Tanaka was previously employed as Vice President-Research & Development by Paratek Pharmaceuticals, Inc. /Old/, Senior Director by PathoGenesis Corp, Project Leader by Abbott Laboratories, a Principal by SCHWARZ PHARMA, Inc., and Scientist by E.R.
Squibb & Sons LLC.
He received his undergraduate degree from the University of Washington and a doctorate degree from Northwestern University.
Eerdere bekende functies van S. Ken Tanaka
| Bedrijven | Functie | Einde |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
| E. R. Squibb & Sons LLC | Hoofd Techniek/Wetenschap/O&O | - |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Corporate Officer/Principal | - |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Directeur/Bestuurslid | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Opleiding van S. Ken Tanaka
| University of Washington | Undergraduate Degree |
| Northwestern University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Health Technology |
Schwarz Pharma, Inc.
Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Health Technology |
| E. R. Squibb & Sons LLC |
